Andere Sprachen Telo Genomics Corp.

Aktien

A2PV0Q

CA87975M2085

TELO

Markt geschlossen - Toronto S.E. Andere Börsenplätze 21:57:14 26.04.2024			% 5 Tage	% 1. Jan.
0,17 ^CAD	-5,56 %		0,00 %	-15,00 %

10.04.	Telo Genomics erhält Akkreditierung vom College of American Pathologists	MT
10.04.	Telo Genomics Corp. erhält Akkreditierung vom College of American Pathologists	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Telo Genomics Receives Accreditation from College of American Pathologists	10.04.
Telo Genomics Receives Accreditation from College of American Pathologists	10.04.
Telo Genomics Corp. Receives Accreditation from College of American Pathologists	10.04.
Telo Genomics' MRD Clinical Trial Expands into Multi-Center Trial; Shares up 9.5%	02.04.
Telo Genomics' Flagship MRD Clinical Trial Expands into Multi-Center Trial	02.04.
Telo Genomics Corp. Announces Patient Recruitment for Its Minimal Respiratory Disease Clinical Trial Has Been Initiated, with Several Patient Samples Received and Processed to Date	02.04.
Telo Genomics Corp. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	27.02.
Telo Genomics Corp. Initiates MRD Clinical Trial for Multiple Myeloma Patients	13.02.
Telo Genomics Initiates MRD Clinical Trial for Multiple Myeloma Patients	13.02.
Telo Genomics Engages US Diagnostics Experts to Power Product Adoption in the US	30.01.
Telo Genomics Corp. Announces Executive Changes	09.12.
Telo Genomics Gears up for American Society of Hematology Conference	06.12.
Telo Genomics Corp. Reports Earnings Results for the First Quarter Ended September 30, 2023	22.11.
Telo Genomics Launches Physician Experience Program in the United States	16.11.
Telo Genomics Advances to the Final Stage of Accreditation from The College of American Pathologists	07.11.
Telo Genomics Corp. Announces the American Society of Hematology Accepts the Results of Teloview-Smm Technical Repeatability Validation for Presentation At Their Annual Meeting in December 10, 2023	01.11.
American Society of Hematology (ASH) Accepts Validation Data from Telo Genomics for Presentation at Upcoming Annual Meeting	01.11.
Telo Genomics Corp. Reports Earnings Results for the Full Year Ended June 30, 2023	31.10.23
Telo Genomics : Consolidated Financial Statements	30.10.23
Telo Genomics Completes International Standards Organization ("ISO") 15189 Final Accreditation	26.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Telo Genomics Corp.

Aktien

A2PV0Q

CA87975M2085

TELO

Andere Sprachen

Filter